Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus
Mohamed F. Mohamed, Ahmed AbdelKhalek, Mohamed N. Seleem
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 241
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
Andrea Miró-Canturri, Rafael Ayerbe-Algaba, Younes Smani
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 188
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 181
Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases
Olga Pacios, Lucía Blasco, Inés Bleriot, et al.
Antibiotics (2020) Vol. 9, Iss. 2, pp. 65-65
Open Access | Times Cited: 178
Statins: a viable candidate for host-directed therapy against infectious diseases
Suraj P. Parihar, Reto Guler, Frank Brombacher
Nature reviews. Immunology (2018) Vol. 19, Iss. 2, pp. 104-117
Open Access | Times Cited: 126
Is There Potential for Repurposing Statins as Novel Antimicrobials?
Emma Hennessy, Claire Adams, F. Jerry Reen, et al.
Antimicrobial Agents and Chemotherapy (2016) Vol. 60, Iss. 9, pp. 5111-5121
Open Access | Times Cited: 123
Pharmacological Targeting of the Host–Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs
Jason Munguia, Victor Nizet
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 5, pp. 473-488
Open Access | Times Cited: 117
New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway
Sheng‐Kai Hsu, Kai‐Chun Cheng, Miracle Oluebube Mgbeahuruike, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9453-9453
Open Access | Times Cited: 58
Simvastatin-hydroxyapatite coatings prevent biofilm formation and improve bone formation in implant-associated infections
Tiantong Sun, Jie Huang, Wang Zhang, et al.
Bioactive Materials (2022) Vol. 21, pp. 44-56
Open Access | Times Cited: 46
Targeting the human gut microbiome with small-molecule inhibitors
Amelia Y. M. Woo, Miguel A. Aguilar Ramos, Rohan Narayan, et al.
Nature Reviews Chemistry (2023) Vol. 7, Iss. 5, pp. 319-339
Closed Access | Times Cited: 23
Strategies for Overcoming Bacterial Resistance to Nanoparticles: A Systematic Review
Pedro Rosales García, Eva Concepción Aguirre López, M.A. Torres, et al.
Cureus (2025)
Open Access | Times Cited: 1
Repurposing auranofin for the treatment of cutaneous staphylococcal infections
Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, et al.
International Journal of Antimicrobial Agents (2016) Vol. 47, Iss. 3, pp. 195-201
Open Access | Times Cited: 82
Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway
Shankar Thangamani, Matthew C. Maland, Haroon Mohammad, et al.
Frontiers in Cellular and Infection Microbiology (2017) Vol. 7
Open Access | Times Cited: 77
Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens
Mostafa F. N. Abushahba, Haroon Mohammad, Shankar Thangamani, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 73
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
Ahmed AbdelKhalek, Nader S. Abutaleb, Khalifa A. Elmagarmid, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Ahmed AbdelKhalek, Nader S. Abutaleb, Haroon Mohammad, et al.
International Journal of Antimicrobial Agents (2018) Vol. 53, Iss. 1, pp. 54-62
Open Access | Times Cited: 67
Statins: antimicrobial resistance breakers or makers?
Humphrey H.T. Ko, Ricky R. Lareu, Brett R. Dix, et al.
PeerJ (2017) Vol. 5, pp. e3952-e3952
Open Access | Times Cited: 65
<p>Formulation and evaluation of simvastatin polymeric nanoparticles loaded in hydrogel for optimum wound healing purpose</p>
Usama Farghaly Aly, Heba A. Abou‐Taleb, Ahmed A. H. Abdellatif, et al.
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 1567-1580
Open Access | Times Cited: 57
Sonoproduction of nanobiomaterials – A critical review
Sze Shin Low, Maxine Yew, Chang Nong Lim, et al.
Ultrasonics Sonochemistry (2021) Vol. 82, pp. 105887-105887
Open Access | Times Cited: 52
Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review
Vitória Segabinazzi Foletto, Taciéli F. da Rosa, Marissa Bolson Serafin, et al.
International Journal of Antimicrobial Agents (2021) Vol. 58, Iss. 3, pp. 106380-106380
Closed Access | Times Cited: 50
Drug repurposing to overcome microbial resistance
Josef Jampílek
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 2028-2041
Closed Access | Times Cited: 35
Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics
Ananda Kumar Konreddy, G. Usha Rani, Kyeong Lee, et al.
Current Medicinal Chemistry (2018) Vol. 26, Iss. 28, pp. 5363-5388
Closed Access | Times Cited: 58
Are the Statins promising antifungal agents against invasive candidiasis?
William Gustavo Lima, Lídia Anita Alves-Nascimento, Jéssica Tauany Andrade, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 111, pp. 270-281
Open Access | Times Cited: 57
A Population-Based Cohort Study on the Drug-Specific Effect of Statins on Sepsis Outcome
Chien‐Chang Lee, Meng-tse Gabriel Lee, Tzu‐Chun Hsu, et al.
CHEST Journal (2017) Vol. 153, Iss. 4, pp. 805-815
Closed Access | Times Cited: 52
Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines
Zhiyuan Fang, Sichao Zheng, Kin‐Fai Chan, et al.
European Journal of Medicinal Chemistry (2018) Vol. 161, pp. 141-153
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top